draft agenda for VC - please make suggestions

2 views
Skip to first unread message

john-w...@novartis.com

unread,
May 22, 2009, 10:39:31 AM5/22/09
to Open Source Laboratory Automation Software
just posted a file (Agenda for VC for Laboratory Automation Open
Source Software Initiative.doc) as a draft for the VC agenda. please
take a look and either modify or email me your thoughts.

Brian Duffy

unread,
May 28, 2009, 5:28:05 PM5/28/09
to Open Source Laboratory Automation Software
Looks good John. Suggest we add next steps & timelines to the general
discussion.

ted.m...@novartis.com

unread,
May 28, 2009, 6:08:17 PM5/28/09
to open-source-laborator...@googlegroups.com

The agenda looks good for me as well, but I agree on us suggesting some topics for the discussion session.  Here's a couple:
  • Are there enough synergies between the various groups' goals that would suggest it makes sense for any of these efforts to be combined?
  • Are there any additional similar efforts that people in this meeting are aware of whom we should also be contacting?

On another note, Dieter Speidel has agreed to give a presentation on SiLA, so we can "ink" him in.  Also, I moved the meeting location to 220 Mass Ave, Room 518 to ensure we have VC capabilities (even though we may just use Webex and teleconference with the multiple sites dialing in).  I'll update the invite in Notes to reflect the room change.


Best,
Ted
Ted Manley
Project Manager, Automation Services - NITAS

Novartis Institutes for BioMedical Research, Inc.
200 Technology Square 830D
Cambridge, MA 02139
USA
Phone: +1 617-871-5152
Fax: +1 617-871-5202
Email :
ted.m...@novartis.com





Brian Duffy <bduf...@gmail.com>
Sent by: open-source-laborator...@googlegroups.com

05/28/2009 05:28 PM


To
Open Source Laboratory Automation Software <open-source-laborator...@googlegroups.com>
cc
Subject
Re: draft agenda for VC - please make suggestions



_________________________

CONFIDENTIALITY NOTICE

The information contained in this e-mail message is intended only for the exclusive use of the individual or entity named above and may contain information that is privileged, confidential or exempt from disclosure under applicable law. If the reader of this message is not the intended recipient, or the employee or agent responsible for delivery of the message to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please notify the sender immediately by e-mail and delete the material from any computer.  Thank you.
Reply all
Reply to author
Forward
0 new messages